Abstract Details

Title Sample Size Requirements for Treatment Effects Using Deep Gray Matter Volume from 3T MRI in Progressive Forms of Multiple Sclerosis

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 173

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Shahamat Tauhid, MD (Brigham & Women's Hospital) PRESENTER	Dr. Tauhid has nothing to disclose.
Renxin Chu (Brigham & Women's Hospital)	Dr. Chu has nothing to disclose.
Gloria Kim (Brigham & Womens Hospital)	No disclosure on file
Fawad Yousuf, MBBS	Dr. Yousuf has nothing to disclose.
Brian C. Healy	The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Rohit Bakshi, MD, FAAN	Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Bakshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. The institution of Dr. Bakshi has received research support from Bristol Myers Squibb. The institution of Dr. Bakshi has received research support from EMD Serono. The institution of Dr. Bakshi has received research support from Novartis.

��ɫ��